Skip to content

Medical-device intelligence

OBH: Monitor, Extracellular Fluid, Lymphedema, Extremity

FDA product code OBH: Monitor, Extracellular Fluid, Lymphedema, Extremity. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OBH
FDA device name
Monitor, Extracellular Fluid, Lymphedema, Extremity
Device class
2
Regulation number
870.2770
Medical specialty
Cardiovascular
Review panel
GU

FDA definition

Measure impedances in affected and unaffected but opposite extremity to periodically monitor the level of extracellular fluid or the differences in bioimpedance between opposing extremities for patients who have been previously diagnosed with unilateral lymphedema (that is, in one affected extremity)
Explore cardiovascular records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

11 clearance records and 1 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Mar 30, 2007 to Oct 28, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202610

Product codes represented

Code and FDA device nameClearancesRecalls
OBH · Monitor, Extracellular Fluid, Lymphedema, Extremity111

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

12 matching records
Device / recordCompany in FDA recordSourceSource date
LymphaTech Mobile 3D Measuring ToolK261628 · OBHLymphatech, Inc.510(k)Oct 28, 2026FDA decision date
MySOZO Software version 6.0.1.2 (SW version 6.0.1.2)K253224 · OBHImpediMed Limited510(k)Jan 28, 2026FDA decision date
SOZO Bilateral Arm L-Dex SoftwareZ-0155-2024 · OBHImpedimed LimitedRecallOct 24, 2023FDA classification date
SOZO ProK230530 · OBHImpediMed Limited510(k)May 4, 2023FDA decision date
MoistureMeterD Compact, LymphScannerK220557 · OBHDelfin Technologies, Ltd.510(k)May 27, 2022FDA decision date
SOZOK180126 · OBHImpediMed Limited510(k)Apr 16, 2018FDA decision date
SOZOK172122 · OBHImpediMed Limited510(k)Aug 11, 2017FDA decision date
MoisturemeterDK143310 · OBHDelfin Technologies, Ltd.510(k)Nov 19, 2015FDA decision date
IMPEDIMED - BIS EXTRA CELLULAR FLUID ANALYSISK130338 · OBHImpediMed Limited510(k)May 31, 2013FDA decision date
IMPEDIMED - EXTRACELLULAR FLUID ANALYZER MODEL: L-DEX U400K100811 · OBHImpediMed Limited510(k)Nov 4, 2011FDA decision date
IMPEDIMED EXTRA CELLULAR FLUID ANALYSIS, MODEL L-DEX U400K080825 · OBHImpedimed Pty , Ltd.510(k)Oct 3, 2008FDA decision date
IMPEDIMED-EXTRACELLULAR FLUID ANALYSISK050415 · OBHImpedimed Pty , Ltd.510(k)Mar 30, 2007FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗